Pancreatic and Biliary Stents Market Size (2024 - 2029)

The pancreatic and biliary stents market is projected to experience growth over the forecast period, driven by an increase in the prevalence of pancreatic cancer and biliary duct diseases, along with technological advancements in stents and endosonography. The market size is expected to expand as minimally invasive surgery gains popularity due to its lower risk compared to open surgeries. However, challenges such as high procedural costs and stringent government regulations may impede the market's growth.

Market Size of Pancreatic and Biliary Stents Industry

Pancreatic and Biliary Stents Market  Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 6.05 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pancreatic and Biliary Stents Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Pancreatic & Biliary Stents Market Analysis

The pancreatic and biliary stents market is expected to register a CAGR of 6.05%, over the forecast period.

The outbreak of the COVID-19 pandemic impacted the global healthcare system and the biliary stents market. For instance, an article published in the journal WJCC, in October 2021, reported that endoscopic ERCP and percutaneous PTC procedures were associated with high rates of viral transmission. Thus, initially, the high number of COVID-19 cases led to increased transmission of infections that led to the suspension of non-emergency surgical procedures including ERCP and PTC procedures, imposed by the government restrictions which impacted the growth of the studied market. However, in the upcoming years, it is anticipated that declining COVID-19 infection rates and the resumption of ERCP and other surgical procedures may increase the demand for the biliary stent, and thus the market is expected to witness significant growth over the forecast period.

The factors that are driving the growth of this market are an increase in the prevalence of pancreatic cancer and biliary duct diseases, technological advancements in stents and endosonographic, and the increasing popularity of minimally invasive surgery. For instance, according to the Globocan 2020 report, globally 132.5 thousand gallbladder cancer cases will be recorded in 2025, and this number is expected to increase to 150.9 thousand by 2030 and to 190 thousand by 2040. Bile duct cancer can lead to the enlargement of a tumor blocking the bile duct. Hence, the placement of a biliary stent can assist in the optimum drainage of the bile; hence, the rising burden of gallbladder cancer is expected to boost market growth. Similarly, an article published by the journal AHPS, in August 2022, reported that high incidence and mortality rates of gallbladder, extrahepatic bile duct, and pancreatic cancer are steadily increasing in Korea. Thus, a high prevalence of gallbladder cancer is expected to drive the demand for biliary stents, thereby driving the growth of the studied market over the forecast period.

Furthermore, with the introduction of new technologies for gastrointestinal surgeries such as bioabsorbable stents and self-expanding metal stents (SEMS), the use of stents for the treatment of pancreatic and biliary diseases is gaining popularity. For instance, in October 2021, Boston Scientific received the 510 (k) US FDA clearance and CE mark approval to market its Advanix biliary plastic stents. Thus, such product launches are driving the growth of the studied market. Moreover, the increasing popularity of minimally invasive surgery (MIS) due to the low risk associated with it compared to open surgeries is increasing the preference for MIS over normal surgeries and thus, fueling the growth of the studied market.

Therefore, due to the increase in the prevalence of pancreatic cancer and biliary duct diseases, technological advancements in stents and endosonography, and increasing popularity of minimally invasive surgery, the pancreatic and biliary market is anticipated to grow over the forecast period. However, the concerns regarding the high cost associated with procedural complexities, and stringent government regulations may slow down the growth of the studied market over the forecast period.

Pancreatic & Biliary Stents Industry Segmentation

As per the scope of the report, a pancreatic and biliary stent is a tubular device made of either plastic or metal inserted into a lumen or duct in the human body to maintain the passage open in the bile or pancreatic duct. Stents may also be used to treat biliary/pancreatic leaks or to prevent post-ERCP pancreatitis. The Pancreatic and Biliary Stents Market is Segmented by Product Type (Plastic Stents and Metal Stents), Application (Benign Biliary Structures, Biliary Leaks, Pancreatic Cancer, and Other Applications), End-User (Hospitals, Ambulatory Surgical Centers and other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bilio-Pancreatic Leakages
Pancreatic Cancer
Other Applications
By End Users
Hospitals
Ambulatory Surgical Centers
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Pancreatic and Biliary Stents Market Size Summary

The pancreatic and biliary stents market is poised for significant growth over the forecast period, driven by an increase in the prevalence of pancreatic cancer and biliary duct diseases, alongside technological advancements in stent and endosonographic technologies. The market's expansion is further supported by the rising popularity of minimally invasive surgeries, which offer reduced risks compared to traditional open surgeries. The COVID-19 pandemic initially hindered market growth due to the suspension of non-emergency surgical procedures; however, as infection rates decline and procedures resume, demand for biliary stents is expected to rise. The introduction of innovative technologies, such as bioabsorbable stents and self-expanding metal stents, is also contributing to the market's growth trajectory.

North America is anticipated to experience substantial growth, fueled by a well-established healthcare infrastructure and a rising prevalence of chronic diseases like prostate, pancreatic, and gallbladder cancers. This region's growth is further bolstered by recent mergers, acquisitions, and partnerships, which are expanding the product portfolios of key market players. The global market remains moderately competitive, with a few companies holding significant market shares, while regional players are expected to increase their presence. Notable companies in the market include Boston Scientific Corporation, Cook Medical Inc, and Medtronic Plc, among others. These developments, coupled with the increasing patient awareness and high disease prevalence, are set to drive the market forward throughout the forecast period.

Explore More

Pancreatic and Biliary Stents Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increase in the Prevalence of Pancreatic Cancer and Biliary Duct Diseases

      2. 1.2.2 Technological Advancements in Stents and Endosonography

      3. 1.2.3 Increasing Popularity of Minimally Invasive Surgery

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost and Complexity Associated with the Procedure

      2. 1.3.2 Stringent Government Regulations

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Plastic Stents

      2. 2.1.2 Metal Stents

    2. 2.2 By Application

      1. 2.2.1 Benign Biliary Structures

      2. 2.2.2 Bilio-Pancreatic Leakages

      3. 2.2.3 Pancreatic Cancer

      4. 2.2.4 Other Applications

    3. 2.3 By End Users

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Pancreatic and Biliary Stents Market Size FAQs

The Pancreatic and Biliary Stents Market is projected to register a CAGR of 6.05% during the forecast period (2024-2029)

Medtronic Plc, CONMED Corporation, Boston Scientific Corporation, Olympus Corporation and Abbott Laboratories are the major companies operating in the Pancreatic and Biliary Stents Market.

Pancreatic and Biliary Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)